Summary:
Recent reports claimed Robert F. Kennedy Jr. fired top Department of Health and Human Services (HHS) officials, but further investigation revealed that Heather Flick Melanson resigned voluntarily. This development follows the FDA’s full approval of Moderna’s Spikevax COVID-19 vaccine for children aged 6 months to 11 years, a decision allegedly made by Vinay Prasad of the FDA’s Center for Biologics Evaluation and Research without Kennedy’s knowledge. The vaccine’s approval has raised concerns due to potential adverse effects, including myocarditis and seizures. Vinay Prasad has since resigned amid controversy.
What This Means for You:
- Parents should consult healthcare providers to assess the risks and benefits of the Spikevax vaccine for their children, especially those with underlying health conditions.
- Stay informed about vaccine-related decisions and ensure you rely on verified sources to avoid misinformation.
- Monitor updates from regulatory bodies like the FDA for changes in vaccine recommendations or safety warnings.
- Be cautious of unverified reports and confirm details with credible news outlets to avoid spreading inaccuracies.
Original Post:
Earlier this month, erroneous reports circulated on the internet and fake news media that Robert F. Kennedy Jr. terminated two top officials at the Department of Health and Human Services (HHS).
Heather Flick Melanson, his Chief of Staff, and Hannah Anderson, Deputy Chief of Staff for Policy, are no longer at HHS.
According to ABC News, the dismissals were sudden and unexplained.
No reason was given for the ousters. The person familiar with the situation told ABC that Kennedy “has every right to make personnel decisions.”
“Secretary Kennedy has made a leadership change within the Immediate Office of the Secretary,” according to a statement provided by an HHS spokesperson to ABC News. “Effective immediately, Matt Buckham will serve as Acting Chief of Staff.”
“Mr. Buckham currently serves as Kennedy’s White House liaison at the U.S. Department of Health and Human Services, where he oversees the recruitment and onboarding of political appointees across the agency. He brings valuable experience in personnel strategy and organizational management to this new role,” the statement continued.
“Secretary Kennedy thanks the outgoing leadership for their service and looks forward to working closely with Mr. Buckham as the Department continues advancing its mission to Make America Healthy Again,” the statement concluded.
Buckham will continue to serve as Kennedy’s White House liaison, according to an administration official.
This story at ABC broke after the FDA — under HHS leadership—officially granted full approval to Moderna’s controversial mRNA COVID-19 vaccine, Spikevax, for children as young as 6 months old through 11 years of age who are deemed “at increased risk” of COVID-19.
The vaccine was previously available to kids under Emergency Use Authorization (EUA), but the FDA has now handed over full approval, greenlighting the use of the experimental shot despite growing evidence of adverse events, including myocarditis, pericarditis, allergic reactions, and even seizures in young recipients.
This was a decision Kennedy was neither authorized nor briefed on.
However, this media report was not accurate.
The Gateway Pundit discovered that Heather Flick Melanson was NOT FIRED but resigned instead.
According to our source, who has intimate knowledge of the details, Heather Flick Melanson is a staunch Trump supporter and was not fired. Heather is also a COVID vax skeptic.
Heather resigned from her post earlier this month and was not fired.
The Gateway Pundit has since learned who it was who approved the Spikevax vaccine for kids.
Vinay Prasad at the Center for Biologics Evaluation and Research (CBER) is allegedly the official who actually approved the Spikevax vaccine for children earlier this month, while everyone was on vacation, without telling the front office.
Vinay Prasad stepped down on Tuesday at the Food and Drug Administration after he was accused of being a leftwing advocate by investigative reporter Laura Loomer.
“Vinay Prasad, as director of the FDA’s Center for Biologics Evaluation and Research, approved Moderna’s Spikevax COVID-19 vaccine for children aged 6 months to 11 years, but only for those with at least one underlying condition that puts them at high risk for severe COVID-19 outcomes. This decision, announced on July 9, 2025, came with a narrower label than Moderna’s initial proposal, which sought approval for all children in that age range.”
This week Vinay Prasad stepped down from the FDA following Laura Loomer’s investigation.
Extra Information:
FDA’s official statement on the approval of COVID-19 vaccines provides insights into the regulatory process. CDC’s guidance on myocarditis and COVID-19 vaccines addresses potential risks. Moderna’s official page on Spikevax offers detailed information on the vaccine’s development and usage.
People Also Ask About:
- What are the side effects of the Spikevax vaccine? Common side effects include myocarditis, pericarditis, and allergic reactions.
- Who approved the Spikevax vaccine for children? Vinay Prasad, formerly of the FDA’s Center for Biologics Evaluation and Research, approved it.
- Was Heather Flick Melanson fired from HHS? No, she resigned voluntarily.
- What is Emergency Use Authorization (EUA)? EUA allows the use of unapproved medical products during public health emergencies.
- Why did Vinay Prasad resign from the FDA? He resigned amid controversy and accusations of bias.
Expert Opinion:
The FDA’s approval of Spikevax for young children underscores the need for transparency in regulatory decisions. Experts emphasize the importance of balancing public health benefits with potential risks, particularly for vulnerable populations. This incident highlights the ongoing debate over vaccine safety and the role of regulatory oversight in healthcare policy.
Key Terms:
- Spikevax COVID-19 vaccine
- FDA approval for children
- Vinay Prasad resignation
- Heather Flick Melanson resignation
- COVID-19 vaccine side effects
- Emergency Use Authorization (EUA)
- Myocarditis and COVID-19 vaccines
ORIGINAL SOURCE:
Source link
